Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

21.27
Delayed Data
As of Jul 02
 -1.16 / -5.17%
Today’s Change
9.38
Today|||52-Week Range
25.56
+76.66%
Year-to-Date

Today’s Trading

Previous close22.43
Today’s open21.58
Day’s range20.41 - 21.60
Volume1,711,392
Average volume (3 months)1,220,238
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+71.35%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
MCRBSeres Therapeutics I...+0.31+0.78%
RLYPRelypsa Inc-0.39-1.18%
ADAPAdaptimmune Therapeu...+0.43+2.45%
ATRAAtara Biotherapeutic...+0.17+0.38%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Richard P. Shea
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers